Northern Trust Corp Cuts Stock Position in Halozyme Therapeutics, Inc. $HALO

Northern Trust Corp cut its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 4.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,740,281 shares of the biopharmaceutical company’s stock after selling 87,490 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Promising Grocery Stocks To Follow Now – August 22nd
Next post Algert Global LLC Invests $890,000 in Electronic Arts Inc. $EA